Z-1009-2023 Class II Ongoing
FDA device recall Z-1009-2023 was initiated by Abbott Molecular, Inc. on December 9, 2022 and is designated Class II. Reason for recall: The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board … The recall status is ongoing. Affected quantity: 918 units.
Recall Details
- Product Type
- Devices
- Report Date
- February 1, 2023
- Initiation Date
- December 9, 2022
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 918 units
Product Description
Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplification, detection, and data reduction.
Reason for Recall
The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board value (calibration data file) referenced causing a misconfiguration of the calibration. 2. Inability of Maintenance and Diagnostics 2300 (Amp Detect Optical Calibrations) to recognize error handling and thermal hold errors during the calibration process, potentially leading to a misconfiguration of the calibration. 3. Under specific conditions during the ADU manufacturing process, an incorrect calibration may potentially have been configured.
Distribution Pattern
x
Code Information
Model Number: 08N53-002